People infected with HIV must take antiretroviral drugs for life. But engineered antibodies appeared to suppress the virus ...

Seven of 10 volunteers kept HIV at bay for months after stopping meds, a rare result scientists call a major step toward a ...

HIV treatment has delivered life-altering advantages. Antiretroviral therapy has led to a reduced mortality and improved life ...

HIV treatment has significantly evolved over the past 30 years, transforming HIV from a fatal disease to a manageable chronic ...

In the small study, seven out of ten participants maintained low levels of HIV for several months after receiving the ...

Merck said on Wednesday its experimental oral HIV medicine was found to be non-inferior to Gilead Sciences' top-selling drug Biktarvy in a late-stage study involving previously untreated adult ...

Pill burden decreases and antiretroviral regimens simplify for many of the participants who start lenacapavir.

You may not realize you’ve benefited from HIV research. But if you’ve received a treatment that was approved through a recent ...

The gel releases a steady dose of the anti-HIV drug lamivudine over six weeks, suggesting people living with HIV could have new therapy that doesn't require a daily pill regimen to prevent AIDS. A new ...

About 40 million people worldwide are living with HIV infection. In the United Kingdom, there are approximately 100,000 people affected. If the infection is not treated, the body will eventually be ...

Drug use, especially injection drug use, presents substantial risks for HIV transmission. Understanding the intricate relationship between drug use and HIV infections is paramount for implementing ...

An oral HIV drug helped patients with center-involved diabetic macular edema achieve improvements in visual acuity, according ...